US

Michael Mahler

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Mahler. Retrieved from https://idiyas.com/inventor/michael-mahler-kli3i33n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Michael Mahler: Innovator in Molecular Biology and Immunology

Introduction

Michael Mahler is a notable inventor in the field of molecular biology and immunology. He has made significant contributions to the diagnosis of systemic autoimmune diseases. His work focuses on developing methods for detecting specific autoantibodies in patients, which is crucial for early diagnosis and treatment.

Latest Patents

Although Michael Mahler currently holds 0 patents, his latest patents include "Compositions And Methods For The Diagnosis Of Systemic Autoimmune Disease" and "Compositions And Methods For The Diagnosis Of Rheumatoid Arthritis." The first patent relates to methods for detecting anti-Th/To autoantibodies in the serum of subjects with systemic autoimmune diseases, such as systemic sclerosis (SSc). The second patent focuses on detecting anti-carbamylated protein (anti-CarP) antibodies in the serum of rheumatoid arthritis (RA) patients.

Career Highlights

Michael Mahler has worked with prominent organizations, including Inova Diagnostics, Inc. and Leiden University Medical Center. His experience in these institutions has allowed him to advance his research and contribute to the understanding of autoimmune diseases.

Collaborations

Michael has collaborated with esteemed colleagues, including Leendert A Trouw and Jan Wouter Drijfhout. These partnerships have enhanced his research efforts and broadened the impact of his work in the scientific community.

Conclusion

Michael Mahler's contributions to molecular biology and immunology are significant, particularly in the diagnosis of autoimmune diseases. His innovative approaches and collaborations continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…